Skip to main content

Entrepreneurs-in-Residence (EIRs)

Entrepreneurs-in-Residence (EIRs)
 

Yale Ventures Entrepreneurs-in-Residence (EIRs) have deep operational experience and have gone through the process of turning new technologies to new businesses. These experts act as an early “sounding board” for Yale innovators contemplating a new startup. In a logical, stepwise fashion, EIRs help frame both the risks and the benefits of starting a new company, asking relevant questions about everything from the science, to the business, to the market and helping faculty chart a successful path forward. Each EIR has decades of practical private-sector experience in building their own companies and valuable connections with industry and investor communities.

200+

Yale Ventures EIRs

5,000+

EIR Mentor Hours Provided for Yale Faculty

140+

Venture Lab Workshops Supported

Therapeutics & Life Sciences EIRs

Jeff Chodakewitz

Image
Jeff Chodakewitz

Jeff Chodakewitz is a physician and R&D leader with three decades of experience, including as Chief Medical Officer and EVP of Global Development at Vertex Pharmaceuticals, senior development leadership roles across the Merck portfolio, and senior advisory work with Blackstone Life Sciences.

In Yale Venture Lab workshops, he brings a clinician’s and drug developer’s eye to early-stage therapeutics. He pushes teams to start with strong biology: what the active molecule is, why the target matters in disease, and what evidence would make the program credible. He also helps founders think through practical development questions early, from clinical validation and indication selection to CMC choices that can shape the path to translation.

Anjali Kumar

Image
Anjali Kumar

Anjali Kumar is a biopharmaceutical business development executive with more than 25 years of experience across Johnson & Johnson, Shire, Wyeth, Pharmacia & Upjohn, and biotechs including Cellarity and Flexion Therapeutics. She has led more than 50 integrated opportunity assessments and more than 100 initial diligences across M&A, licensing, options, and research collaborations.

In Yale Venture Lab workshops, she pushes teams to articulate the real value to discovery and development stakeholders, avoid overpromising, and define credible experiments and assays that demonstrate differentiation and time and cost savings.

Colin Foster

Image
Colin Foster

Colin Foster is a life sciences CEO and board leader with 30+ years of experience building, financing, and turning around companies across therapeutics, diagnostics, and medical devices. He has held senior leadership roles at Bayer, served as CEO of Bioblast Pharma, and is currently Chairperson and CEO of Cytosolix, Chairperson of Saatient Therapeutics, and a board member of NBO Pharma.

In Yale Venture Lab workshops, he pushes teams to act like a biotech by building a clear business case, sharpening IP and indication portfolio strategy, and choosing the right path to execution based on funding realities and the cost to generate a credible data package.

Medical Devices & Digital Health EIRs

Roaida Johnson

Image
Roaida Johnson

Roaida Johnson is a regulatory affairs leader with 20+ years of medical device experience and is the Owner and Principal Regulatory Consultant at Lambint, LLC. She advises companies on practical FDA pathway strategy across software and diagnostics, including how to position clinical decision support tools, select an appropriate route such as 510(k) or De Novo when needed, and plan evidence requirements.

In Yale Venture Lab workshops, she helps teams de risk regulatory execution by clarifying what triggers FDA oversight, setting realistic data and validation expectations across sites and demographics, and protecting sensitive datasets through mechanisms such as master files when disclosure is required.

Joe Honcz

Image
Joe Honcz

Joe Honcz is a healthcare executive and market access strategist with 25+ years of experience across managed care, biopharma, and healthcare policy, including roles at Pfizer, CVS, and Walgreens, and he now advises emerging companies at Petauri Health. He also contributed to major U.S. coverage expansions, including the launch of Medicare Part D and implementation of the Affordable Care Act.

In Yale Venture Lab workshops, he pushes teams to translate capabilities into reimbursable value by defining the unit of product, building a clear product map, tying pricing to volume and outcomes, and choosing a funding strategy that fits the business model.

John Hendershot

Image
John Hendershot

John Hendershot is Vice President of Global Marketing for Medtronic’s Advanced Surgical Instruments business, where he leads portfolio strategy, the innovation pipeline, and commercialization approaches for surgical technologies. 

In Yale Venture Lab workshops, he pushes teams to treat the technology as a commercial product by mapping the competitive landscape, sharpening the value proposition and business model, and planning early for regulatory and reimbursement.

Engineering & Applied Science EIRs

Melissa Fensterstock

Image
Melissa Fensterstock

Melissa Fensterstock is a life sciences operator and investor and currently a Principal at Material Impact Fund. She previously served as CEO of Lansdowne Labs, a venture co founded with Dr. Robert Langer, where she translated an academic concept into a commercial child safety technology through grant funding, venture financing, policy work, and a global strategic partnership.

In Yale Venture Lab workshops, she pushes teams to sharpen narrative and category positioning, lead with commercial traction, and align the business model with investor expectations by staying close to the customer and avoiding capital intensive equipment sales when finished product economics are stronger.

John Derrick

Image
John Derrick

John Derrick is the CEO and founder of Authentrics.ai, an AI infrastructure company focused on explainability, control, and resilience for neural networks through checkpoint native, weight level tooling for production AI pipelines. He is a multi time CEO and operator with nine exits across CEO and interim or advisory roles, and he is an inventor with 20 patents from prior work including IBM and Intel.

In Yale Venture Lab workshops, he helps teams translate technical capability into deployable products by stress testing where value accrues in real world settings, clarifying scalable deployment and integration paths such as containerized software and cloud pipelines, and pushing early market sizing, differentiation, pricing tests, and customer discovery so a single product can grow into a platform.

Mark Jackson

Image
Mark Jackson

Mark Jackson is a quantum physicist and Senior Quantum Evangelist at Quantinuum, where he advises executives and technical teams on practical applications of quantum computing. He previously spent a decade in superstring theory and cosmology research, co authoring nearly 40 publications, and he is active in science communication and advising through roles including Adjunct Faculty at Singularity University and Director at Astronomers Without Borders.

In Yale Venture Lab workshops, he helps teams clarify where quantum approaches offer real advantages, communicate the idea clearly to non specialists, and define practical milestones that connect a concept to a defensible proof of concept.

Investors, Operators & Commercialization Experts EIRs

Priyanka Bakaya

Image
Priyanka Bakaya

Priyanka Bakaya is a global leader in energy innovation and commercialization, passionate about advancing breakthrough technologies. Priyanka began her career in finance and venture capital before founding and scaling an award-winning energy startup, gaining firsthand insight into the challenges and opportunities of bringing new technologies to market. She currently serves as an advisor on Technology-to-Market commercialization for the U.S. Department of Energy’s Advanced Research Projects Agency–Energy (ARPA-E), and sits on the Impact Committee of the Circular Innovation Fund and the Advisory Board of the Collab SOS Fund. She has also trained founders on entrepreneurship and sustainability for many years through MIT Bootcamps.

Recognized by Forbes (30 Under 30 Energy), Fortune (40 Under 40: Ones to Watch), the Cartier Women’s Initiative as a Laureate, and the World Economic Forum as a Young Global Leader, Priyanka has been invited to speak on six continents. Her featured appearances include Fortune Brainstorm Green, Davos, Sustainable Brands, the Global Entrepreneurship Summit, World Economic Forum, TEDx, and other leading global forums.

A graduate of MIT Sloan and Stanford University with Honors, Priyanka has also completed executive education at Harvard Kennedy School and Princeton’s Andlinger Center for Energy and the Environment.

Eric Rubenstein

Image
Eric Rubenstein

Eric Rubenstein is Managing Partner at New Climate Ventures (“NCV”). Launched to tackle climate change with a diversified approach, NCV invests in innovative early-stage startups broadly across the carbon removal, reduction and avoidance ecosystems. NCV officially launched in October 2021, and has invested in companies that span the areas of climate tech, recycling, alternative materials, food tech, and energy transition, among other emissions avoiding technologies. Prior to founding New Climate Ventures, Eric held investment, fundamental strategy, and trading roles at Citigroup and Louis Dreyfus in their commodities and energy trading divisions respectively. 

A psychology major with a focus on behavioral neuroscience, Eric graduated Yale University with a Bachelor’s degree. After graduating Yale, Eric received his MBA from Temple University with a focus on global business and entrepreneurship.

Megha Unhelkar

Image
Meha Unhelkar

Megha H. Unhelkar joins the 2021 Blavatnik Fellowship as an entrepreneur and a scientist with a passion for improving healthcare.

Prior to the Blavatnik Fellowship, Megha was a Life Sciences Strategy Consultant with Charles River Associates, performing early-stage product feasibility assessments to help guide commercial development of therapies across different areas including oncology, immunology, and rare diseases. Megha’s industrial experience includes working at Celgene to understand the drug metabolism and pharmacokinetics of cancer targeting drugs and at BASF, investigating enzyme kinetics.

Megha earned her PhD in Biophysical Chemistry from the University of California, Irvine, where she invented a bioinformatics pipeline to discover new proteins from carnivorous plants to characterize them using NMR. She also earned her MS in Pharmacology from Northeastern University, Boston and BS in Pharmacy from the University of Mumbai. Outside of work, Megha has founded and runs a non-profit called “The Science of Colors”. She also enjoys cooking, reading, and running; she is training for the Chicago 2022 Marathon.

Cultural Innovation EIRs

Michael Bobbitt

Image
Michael Bobbitt

Michael J. Bobbitt is a nationally recognized arts executive, producer, and artist with over 20 years of experience across public policy leadership, organizational transformation, and creative practice. Michael is currently President and CEO of OPERA America, leading the national service organization for the opera field from New York City. He has a strong record of leading complex institutions, scaling organizations, and building cross-sector partnerships spanning arts, education, health, and economic development.

Previously, Michael served as Executive Director of the Mass Cultural Council, where he was Massachusetts’ highest-ranking public official for arts and culture. In this role, he led strategy and operations for a $29.7B creative economy, secured $60.1 million in COVID-19 relief, increased annual state appropriations from $18.2 million to $26.9 million, and embedded the arts into statewide health, education, and economic policy initiatives. During his tenure, he was appointed by the Governor to the Advisory Council on Black Empowerment, the Statewide K–12 Graduation Council, the Mass STEM Advisory Council, and the Massachusetts Cultural Policy Development Advisory Council. Michael also previously served as Producing Artistic Director of New Repertory Theatre and as Artistic Director of Adventure Theatre MTC, where he quadrupled fundraising, commissioned more than 50 new works, and pioneered nationally adopted autism-inclusive and sensory-friendly performances.

Michael is also an accomplished playwright, director, and choreographer whose work includes major adaptations and premieres such as Bob Marley’s Three Little Birds, The Stephen Schwartz Project, Garfield: The Musical with Cattitude, Jumanji, and Big the Musical (TYA), among many others. His work has earned multiple Helen Hayes Award nominations, including for the Charles MacArthur Award for Outstanding New Play or Musical, with directing and choreography credits at institutions including the Kennedy Center, Washington National Opera, Ford’s Theatre, La Jolla Playhouse, and Singapore Repertory Theatre.

Bobbitt is a proud alumnus of the University of Massachusetts Amherst and holds an M.B.A. in Arts Innovation from the Global Leaders Institute. He received an honorary Doctor of Fine Arts, honoris causa from Dean College and has completed executive education at Harvard Kennedy School, Harvard Business School, and National Arts Strategies. He is a Kennedy Center Gold Medallion recipient, a Fellow of the College of Fellows of the American Theatre, and has taught at institutions including Boston Conservatory at Berklee, Howard University, and George Washington University.

Michael Uy

Image
Michael Uy

Michael Sy Uy (he/him) is Associate Professor of Musicology and Director of the American Music Research Center. His main areas of scholarly research are on philanthropy, patronage, arts education, cultural policy, expertise and connoisseurship. His first book—Ask the Experts: How Ford, Rockefeller and the NEA Changed American Music—was published by Oxford University Press in 2020. He is currently working on his second book—Endowing Equity: The NEA, Minority Artists and the Battle for Arts Funding—which has been supported by an American Council of Learned Societies (ACLS) fellowship. He is co-editor of the volume Musical Capital: Sound and Power in Washington, D.C. (Dumbarton Oaks: Harvard University Press, under contract) and co-series editor of Arts in Context: Critical Performance Infrastructures (University of Texas Press). His other published work appears in American Music, Journal of the Society for American Music, Journal of Musicology and Music and Arts in Action.

Prior to CU Boulder, Uy was Assistant Dean of Harvard College and the Allston Burr Resident Dean of Dunster House (2017-23), as well as a Lecturer in the Music Department. He completed his BA at UC Berkeley, MPhil at Oxford University and PhD at Harvard University. He is the recipient of several teaching awards including the Mindich Program in Engaged Scholarship’s Curricular Innovation Award, the Derek Bok Center Excellence in Teaching Award, and the Distinguished Faculty Award from the Harvard Foundation.

Mara Isaacs

Image
Mara Isaacs

Mara Isaacs is a Tony® and Grammy® Award-winning creative producer, recognized as a leader in developing and producing new plays, musicals and multi-disciplinary work across the globe. Mara generates opportunity through the organizations and programs she creates: Octopus Theatricals, to produce an expansive body of work—from experimental to commercial; Octoverse Media, an independent record label and multi-media platform; Producer Hub, providing professional resources and community to producers and artists in the independent sector;  and Arts Impact Collaborative, to tell compelling stories documenting the essential role the arts play in communities throughout the US.  

Selected production highlights:  Hadestown (Broadway, West End, North American Tour; Best Musical Tony and Grammy); Gypsy with Audra McDonald (Broadway); Goddess (Public Theatre 2025); Patrick Page’s All the Devils Are Here (off-Broadway, US Tour); (…Iphigenia) a new opera by Wayne Shorter and Esperanza Spalding (premiere and US tour); Theatre for One (US, Ireland, Kenya). In Development: Bhangra Nation; The Queen’s Gambit; I Feel Myself to be Part of Something (documentary film series) and more.

Mara is currently an Entrepreneur in Residence with Yale Ventures.  She serves on the boards of Producer Hub, the Dramatists Legal Defense Fund, Almasi Arts Alliance and the Broadway League, and as a member of the Tony Administration Committee and American Theatre Wing Advisory Board. Previously: Producing Director at McCarter Theatre Center in Princeton, NJ and Associate Producer at the Mark Taper Forum/Center Theatre Group in Los Angeles.